[Results of a controlled experiment of the titrated extract of Centella asiatica in a leper population with perforative foot lesions].
D000287:Administration, Topical; D000349:Africa; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005528:Foot / Q000000981:diagnostic imaging; D005534:Foot Diseases / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007273:Injections, Intramuscular; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D007918:Leprosy / Q000150:complications / Q000188:drug therapy*; D009161:Mycobacterium / Q000302:isolation & purification; D011859:Radiography; D012038:Regeneration / Q000187:drug effects; D014329:Tropical Climate
D007917:Leprostatic Agents
Résultats d'un essai controlé de l'extrait titré de Centella asiatica (E.T.C.A.) (I)dans une population lépreuse présentant des maux perforants plantaires]